Business
Emerald Organic Products, Inc. Announces Exclusive Licensing Agreement With PetVivo Holdings Inc.
Emerald Organic Products, Inc. Announces Exclusive Licensing Agreement With PetVivo Holdings Inc..
About this update from Healixa Inc.
[{"type":"text","content":"\nNew York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) (“Emerald” or the “Company”) is pleased to announce that it has formally entered into an exclusive licensing agreement for the use of OraPatch™, a patented oral delivery method for various substances including caffeine and cannabidiol (“CBD”) from PetVivo Holdings, Inc. (OTC:PETV) (“PetVivo”). \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n The patented oral adhesion technology, OraPatch™, is a slowly degradable protein wafer-disc that attaches to and assimilates with the mouth's inner lining. PetVivo is the holder of patents for this unique and cutting-edge method for nutraceutical and supplement delivery.  The fully dissolving wafer-like invention sticks strongly and comfortably the roof of the mouth, cheeks, or gums. This delivery method provides both a rapid release and greater bioavailability when compared to ingestion. Furthermore, the OraPatch product only uses materials deemed to be Generally Recognized as Safe (“GRAS”) by the United States Food and Drug Administration (the “FDA”). “The potential introduction of this technology to our line of products can change the entire dynamics and approach to both our vitamin and nutraceutical markets, especially for our flagship PURA CBD products” said Emerald Organic Products, Inc. CEO, Ian Parker.  John Lai, President of PetVivo said, “We were waiting for the right consumer branding team to license this extraordinary, cutting edge technology to. Clearly, the management pedigree of Emerald is best-in-class in the emerging cannabinoid market.” Lai continued, “In the right hands, this product has the potential to revolutionize the vitamin and CBD market place and we are confident we found the right team partner in Emerald.” Using safe materials, the efficiency afforded by this new patented delivery technology may allow for enhanced bioavailability and efficacy while employing lower and more exact product doses, thereby reducing potential stomach irritations and risks of toxicity. “There is no delivery system like it in the market. The potential use of this brand new delivery method breakthrough, known as the “OraPatch” can create a paradigm...